| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |